State of the science: beta-blockers and reduction of perioperative cardiac events.
This article evaluates the current literature concerning the use of perioperative beta-blockade to reduce cardiac events in hopes that it may provide direction to clinicians or demonstrate gaps in medical knowledge, thus revealing areas suitable for future study. The current standard of practice for the use of perioperative beta-blockade in preoperative patients is outlined in the American College of Cardiology (ACC) and American Heart Association (AHA) guidelines. Findings differ as to the risk and benefit of using beta-blockers perioperatively to reduce cardiac events. Further research is needed to support the ACC/AHA recommendations. It is essential that the decision to use beta-blockade be made on a case-by-case basis with adequate risk stratification as part of the criteria.
Stephens
Seth
S
Texas Tech University Health Sciences Center, Anita Thigpen Perry School of Nursing, 3601 4th Street, Stop 6264, Lubbock, TX 79430-6264, USA. Seth.Stephens@ttuhsc.edu
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002985:Clinical Protocols; D055317:Evidence-Based Practice; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D018579:Patient Selection; D019990:Perioperative Care / Q000379:methods* / Q000451:nursing / Q000592:standards; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D017751:Safety Management
D000319:Adrenergic beta-Antagonists